It has been reported in literature that antibodies specific for Platelet Factor 4 (PF4) were present at high levels in patients who presented thrombosis after vaccination with the AstraZeneca ChAdOx1 nCoV-19 vaccine [8,16]. This evidence concerns the gene PF4 and Venous thrombosis.